Biotech Rallies On Bullish Earnings
03 September 2021 - 6:20AM
AllPennyStocks.com
Fundamental insights via quarterly earnings
statements into stocks trading OTC, no matter the tier, are always
a refreshing event that allows investors to feel better in tuned
with the company. While these company’s typically aren’t frequently
covered by analysts from big banks, individuals can learn a ton by
reading the headlines and digging through key metrics within the
financial statements. Shares of Integrated Biopharma Inc.
(OTCQX:INBP) rallied today after the
company reported financial results for its quarter and fiscal year
ended June 30, 2021. While the amount of information is rather
robust, the highlights are as follows. Revenue for the quarter was
$17.1 million compared to $13.5 million for the same quarter a year
ago. Operating income for the quarter was $1.3 million when
compared to $0.6 million. For the year, total revenue was $63.6
million, which is an increase of 20.5% YoY.
Integrated Biopharma Inc. is a pharmaceutical
company which is engaged primarily in manufacturing, distributing,
marketing, and sales of vitamins, nutritional supplements, and
herbal products through its subsidiaries. It operates in two
segments namely Contract Manufacturing and Other Nutraceutical
Businesses. The company generates maximum revenue from the Contract
Manufacturing segment. Geographically, it derives a majority of
revenue from the United States.
Traders were bullish on the financials as the
share price climbed up to $1.04/share (+10.05%) at the session
high. This move could be an indication of things to come as the
stock has been sliding a bit since making its 52-week high of $1.25
back in May.
To read the full story on AllPennyStocks.com, click
here.
Integrated BioPharma (QX) (USOTC:INBP)
Historical Stock Chart
From Sep 2024 to Oct 2024
Integrated BioPharma (QX) (USOTC:INBP)
Historical Stock Chart
From Oct 2023 to Oct 2024